Table 4.

Curative therapy according to race and treatment modality.

	Full sample N (%)			Low benefit a N (%)			Intermediate benefit b N (%)			High benefit c N (%)
	Black	White	P-value d	Black	White	P-value d	Black	White	P-value d	Black	White	P-value d
Any curative therapy	3781	41,152	<0.001	1270	13,698	<0.001	1912	21,108	<0.001	599	6346	<0.001
	(56.2)	(66.3)		(51.9)	(57.2)		(57.2)	(69.6)		(64.2)	(81.4)
Treatment modality
Radical prostatectomy	752	10,587	<0.001	170	2113	0.002	373	5473	<0.001	209	3001	<0.001
	(11.2)	(17.1)		(7.0)	(8.8)		(11.2)	(18.0)		(22.4)	(38.5)
External beam radiation	2104	18,810	0.09	728	6917	0.34	1103	9824	0.49	273	2069	0.08
	(31.3)	(30.3)		(29.8)	(28.9)		(33.0)	(32.4)		(29.3)	(26.6)
Brachytherapy	925	11,755	<0.001	372	4668	<0.001	436	5811	<0.001	117	1276	0.003
	(13.8)	(18.9)		(15.2)	(19.5)		(13.0)	(19.2)		(12.5)	(16.4)

^aLow-benefit: low-risk tumors and life expectancy <10 years.

^bIntermediate-benefit: low-risk tumors and life expectancy ≥10 years or moderate-risk tumors and life expectancy <10 years.

^cHigh-benefit: moderate-risk tumors and life expectancy ≥10 years.

^dP-value is for bivariate test of receipt of curative therapy between black and white patients within each row.